EconomyChina targets five innovative drugs with US$1 billion returns by 2030. Which could make the list?

Growing global interest in Chinese novel therapies has helped turn the country into a biomedical powerhouse, though no Chinese drug has yet matched the sales of Western all-time bestsellers. Beijing’s new five-year goals include at least five products with annual global sales above US$1 billion by 2030, a target some analysts consider achievable.

Chinainnovative drugsbiomedicinedrug sales

SSouth China Morning Post★★☆☆☆2026-10-10 00:00Original